Breaking

200-Day Moving Average Confirms Bearish Phase
Top Pentagon official John Ullyot to resign at end of week: report
Scoop: Republican National Committee showcases record fundraising as party builds 2026 war chest
CIA director says China is #1 priority, poses biggest challenge from adversary in US history
Trump admin guts AmeriCorps, Clinton-era volunteer agency that failed 8 consecutive audits
‘Mass surveillance’: Conservatives sound alarm over Trump admin’s REAL ID rollout
Republican uses George Washington, American Revolution to reject notion Ukraine should surrender to Russia
Trump takes center stage in Canada’s prime minister election debate

Home
Features
- View All On Demos
Buy Now
Search for:

Investing

Agreement with Vytas Ltd for High Purity Assay Services

November 28, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

ChemX Materials (CMX:AU) has announced Agreement with Vytas Ltd for High Purity Assay Services

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

NorthStar Gaming to Host Q4 and Year-End 2024 Earnings Webinar on April 29th

Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties

Canadian Investment Regulatory Organization Trade Resumption – FYL

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (319)
- Investing (1,026)
- Politics (1,262)
- Stocks (394)

Disclaimer: 2morrowgrowth.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 2morrowgrowth.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.